Jagat Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 4.30 M
- Paid Up Capital ₹ 3.00 M
- Company Age 28 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 15.71%
- Profit Growth 46.97%
- Ebitda 130.10%
- Net Worth 7.88%
- Total Assets 7.87%
About Jagat Diagnostics
Jagat Diagnostics Private Limited (JDPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 June 1996 and has a history of 28 years and eight months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.30 M and a paid-up capital of Rs 3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ankush Goyal and Lokesh Jindal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397DL1996PTC079707
- Company No.
079707
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Jagat Diagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lokesh Jindal  | Director | 18-Jan-2010 | Current |
| Ankush Goyal | Director | 15-Jun-2013 | Current |
Financial Performance of Jagat Diagnostics.
Jagat Diagnostics Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 15.71% increase. The company also saw a substantial improvement in profitability, with a 46.97% increase in profit. The company's net worth moved up by a moderate rise of 7.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jagat Diagnostics?
In 2020, Jagat Diagnostics had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Karwa Enterprises Private LimitedAnkush Goyal is a mutual person
- Deep Laboratories Private Limited
Ankush Goyal is a mutual person
- Goldline Laboratories Private Limited
Ankush Goyal is a mutual person
- Tls Agros India Private Limited
Ankush Goyal and Lokesh Jindal are mutual person
- Aspen Laboratories Private Limited
Ankush Goyal is a mutual person
- Deep Meditech Private Limited
Ankush Goyal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jagat Diagnostics?
Unlock and access historical data on people associated with Jagat Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jagat Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jagat Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
